Legal Representation
Attorney
John W. McIlvaine, Registration No. 34,219
USPTO Deadlines
Next Deadline
1250 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-12-20)
Due Date
December 20, 2028
Grace Period Ends
June 20, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 20, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 20, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 4, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 4, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 14, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 26, 2022 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
| Aug 19, 2022 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Aug 12, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 12, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 12, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 12, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 12, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 19, 2022 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 19, 2022 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 19, 2022 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jan 11, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 11, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 11, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 12, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 12, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 12, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 8, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 23, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 18, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific laboratory services; computer system analysis in relation to computerised data; analysis of medical data for scientific and medical research and development purposes; scientific laboratory services, namely, t-cell repertoire decoding services for scientific and medical research and development purposes; scientific laboratory services, namely, sequencing of cells for scientific and medical research and development services; Platform as a Service (PaaS) featuring computer software platforms for scientific and medical research and development, t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Platform as a Service (PaaS) featuring computer software platforms for t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Software as a Service (SaaS) services featuring software for scientific and medical research and development services, t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Software as a Service (SaaS) services featuring software for t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Software as a Service (SaaS) services featuring software for predicting, determining and analysing t-cell specificity; Software as a Service (SaaS) services featuring software for describing the profiles of t-cell receptors and t-cell receptor sequences; scientific research, namely, single cell immune profiling and analysis services; scientific research, namely, t-cell specificity analysis services; pharmaceutical research and development services; medical research services, namely, prediction of immune response, identification of pathogens for medical purposes, t-cell repertoire decoding services for medical purposes, and sequencing of cells for medical purposes; information, advisory and consultancy services relating to the aforesaid
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical services; medical diagnostic services; medical analysis services related to the treatment of patients; analysis of medical data for the diagnosis and treatment of persons; medical services, namely, immunotherapy services; medical care, namely, personalized medical services; provision of medical information; provision of medical information regarding t-cells, identification of pathogens, immune response and the treatment of disease; information, advisory and consultancy services relating to the aforesaid
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042
044